Alto Neuroscience Inc. (ANRO)
NYSE · Manufacturing · Pharmaceutical preparations
ANRO price, last 12 months
Key stats
- Previous close
- $25.91
- Open
- $26.20
- Day range
- $25.21 – $26.70
- 52-week range
- $12.51 – $37.48
- Volume
- 573K
- Avg volume (20 days)
- 616.9K
- Market cap
- $1.2B
Performance
Technicals and fundamentals
About Alto Neuroscience Inc.
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NYSE
- Market cap
- $1.2B